Clinical Trial Update: A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and effectiveness of MK-0974 (telcagepant) co-administered with ibuprofen or acetaminophen in patients with migraines with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MK-0974 (telcagepant) (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2014-08-11